RecruitingNot Applicable

De Quervain's Disease in the Acute Phase:a Study Aimed at Evaluating the Effectiveness of Standard Physiotherapy Treatment (HANDGUIDE), Compared to Experimental Treatment After Performing Ultrasound-guided Infiltrative Therapy.

Italy134 participantsStarted 2024-02-27

Plain-language summary

The objective of the study is to compare pain reduction and disability reduction in two groups of patients diagnosed with de Quervain syndrome who will undergo ultrasound-guided infiltrative treatment with corticosteroid as per normal clinical practice: * the control group will subsequently be subjected to a standard treatment based on the European guidelines of the HANDGUIDE group, * the experimental group will subsequently carry out a program of eccentric exercises.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients of both sexes with a minimum age of 18 years; * Medical diagnosis of de Quervain syndrome assessed through orthopedic clinical examination e confirmation by ultrasound; * Signing of the informed consent and participation in the study. Exclusion Criteria: * Patients who are not self-sufficient or not able to understand and want; * Presence of other pathologies in the hand affected by de Quervain pathology, such as intersection syndrome, neuropathies, fractures, rhizoarthrosis, arthrosis of the radio-carpal or intercarpal joint, intercarpal instability, cervical radiculopathy, rheumatic or metabolic pathologies; * Pregnant or breastfeeding women.

What they're measuring

Numeric Pain Rating Scale

Timeframe: At baseline (day 0)

Numeric Pain Rating Scale

Timeframe: After 1 month

Numeric Pain Rating Scale

Timeframe: After 3 months

Numeric Pain Rating Scale

Timeframe: After 6 months

Trial details

NCT IDNCT06296472

SponsorIstituto Ortopedico Rizzoli

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05-30

Contact for this trial

Federico Pilla, MD

0516366 federico.pilla@ior.it

View on ClinicalTrials.gov More De Quervain Disease trials

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.